Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00116519 | A Study in People With Abnormal Fat Levels in the Blood | PHASE2 | COMPLETED | 300 | — | — | Jul 1, 2005 | Oct 1, 2006 | Jan 26, 2007 | 54 | United States |
| Name | Type | Description |
|---|---|---|
| PPAR alpha | DRUG | - |
| placebo | DRUG | - |
Inclusion Criteria: * Men and women between 18 and 80 years of age * People with abnormal fat levels in the blood (low HDL, high TG) Exclusion Criteria: * People with diabetes * People whose blood pressure is greater than 160/95 mm Hg, on or off blood pressure medicine * People who have had frequ...